HomeMURA • NASDAQ
add
Mural Oncology plc
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.97M | -88.37% |
Net income | -3.71M | 88.33% |
Net profit margin | — | — |
Earnings per share | -0.21 | 88.77% |
EBITDA | -3.17M | 90.46% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 58.87M | -66.46% |
Total assets | 65.76M | -67.65% |
Total liabilities | 10.57M | -63.71% |
Total equity | 55.19M | — |
Shares outstanding | 17.34M | — |
Price to book | 0.64 | — |
Return on assets | -12.93% | — |
Return on capital | -16.16% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -3.71M | 88.33% |
Cash from operations | 1.00M | 103.32% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | -16.78M | 12.31% |
About
Founded
2017
Website
Employees
104
